Want to see QSI full AI Analyst Report?
QSI Stock Chart & Stats
$0.79
$0.01(1.73%)
At close: 4:00 PM EDT
$0.79
$0.01(1.73%)
Day’s Range― - ―
52-Week Range$0.69 - $3.10
Previous Close$0.78
Volume1.09M
Average Volume (3M)5.42M
Market Cap
$334.89M
Enterprise Value$84.27M
Total Cash (Recent Filing)$111.74M
Total Debt (Recent Filing)$3.25M
Price to Earnings (P/E)―
Beta3.12
Next Earnings
Nov 11, 2026EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.46
Shares Outstanding198,946,410
10 Day Avg. Volume13,404,087
30 Day Avg. Volume5,416,517
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.99
Price to Sales (P/S)89.30
P/FCF Ratio-2.24
Enterprise Value/Market Cap0.25
Enterprise Value/Revenue52.50
Enterprise Value/Gross Profit149.94
Enterprise Value/Ebitda-0.93
Forecast
1Y Price Target
$2.95Price Target Upside273.42% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.43
Revenue Forecast (FY)$1.13M
Bulls Say, Bears Say
Bulls Say
Low LeverageVery low leverage limits debt-related financial risk and preserves flexibility while Quantum-Si develops its platform. The company is less exposed to interest expense and refinancing pressure, although continued losses still require careful capital management.
Extended Cash RunwayA cash runway extending into Q4 2028 gives Quantum-Si time to fund Proteus development, customer preparation, and commercialization without an immediate financing requirement. Planned cost reductions further improve the company’s ability to execute through the launch period.
Proteus Technology ProgressProgress toward detecting all 20 amino acids strengthens Proteus’s technical proposition and could improve its usefulness across proteomics workflows. If translated into a routine sequencing kit, broader amino-acid coverage may support differentiation and future customer adoption.
Bears Say
Declining RevenueThe sharp revenue decline shows that current commercial traction remains weak and that the installed base is not yet generating enough instrument, consumables, or service revenue to support the business. Sustained weakness can delay scale benefits and increase reliance on cash reserves.
Persistent Cash BurnLarge recurring losses and negative EBITDA indicate that operating spending substantially exceeds the current revenue base. Continued cash burn reduces financial flexibility over time and makes successful Proteus execution and eventual recurring consumables adoption important to long-term sustainability.
Proteus Launch DelayA later Proteus launch postpones customer evaluations, early access, and potential revenue conversion from the company’s main development program. The delay also extends the period in which Quantum-Si must fund operations while generating limited revenue from its existing platform.
Quantum-Si News
QSI FAQ
What was Quantum-Si’s price range in the past 12 months?
Quantum-Si lowest stock price was $0.69 and its highest was $3.10 in the past 12 months.
What is Quantum-Si’s market cap?
Quantum-Si’s market cap is $334.89M.
When is Quantum-Si’s upcoming earnings report date?
Quantum-Si’s upcoming earnings report date is Nov 11, 2026 which is in 30 days.
How were Quantum-Si’s earnings last quarter?
Quantum-Si released its earnings results on Aug 13, 2026. The company reported -$0.11 earnings per share for the quarter, beating the consensus estimate of -$0.113 by $0.003.
Is Quantum-Si overvalued?
According to Wall Street analysts Quantum-Si’s price is currently Undervalued.
Does Quantum-Si pay dividends?
Quantum-Si does not currently pay dividends.
What is Quantum-Si’s EPS estimate?
Quantum-Si’s EPS estimate is -0.12.
How many shares outstanding does Quantum-Si have?
Quantum-Si has 198,946,410 shares outstanding.
What happened to Quantum-Si’s price movement after its last earnings report?
Quantum-Si reported an EPS of -$0.11 in its last earnings report, beating expectations of -$0.113. Following the earnings report the stock price went down -6.456%.
Which hedge fund is a major shareholder of Quantum-Si?
Currently, no hedge funds are holding shares in QSI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Quantum-Si Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.95 (273.42% Upside)
$2.95 (273.42% Upside)
Blogger Sentiment
Neutral
QSI Sentiment 100%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Increased
By 276.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $39.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.06%
12-Months-Change
Fundamentals
Return on Equity
-47.12%
Trailing 12-Months
Asset Growth
-23.91%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Quantum-Si
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
QSI Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed a balanced message: positive technical progress, strengthened commercial insights and a clarified plan to preserve cash and extend runway into Q4 2028, but offset by a meaningful delay to Proteus launch, significant year-over-year revenue declines, a ~20% workforce reduction and continued operating losses. Management framed the delay as a responsible decision to de-risk launch and emphasized cost actions and market preparation, while acknowledging near-term headwinds to revenue and timing of customer access.View all QSI earnings summariesQSI Stock 12 Month Forecast
Average Price Target
$2.95
▲(273.42% Upside)
Technical Analysis
Ownership Overview
22.23% Insiders
6.85% Mutual Funds
0.04% Other Institutional Investors
61.83% Public Companies and
Individual Investors